EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+15.49%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$11.9B
AUM Growth
+$4.1B
(+53%)
Cap. Flow
+$2.9B
Cap. Flow
% of AUM
24.37%
Top 10 Holdings %
Top 10 Hldgs %
28.21%
Holding
960
New
318
Increased
304
Reduced
85
Closed
35
Top Buys
| 1 |
NVIDIA
NVDA
|
$175M |
| 2 |
Microsoft
MSFT
|
$170M |
| 3 |
Apple
AAPL
|
$123M |
| 4 |
Abbott
ABT
|
$98.9M |
| 5 |
Intuit
INTU
|
$97.9M |
Top Sells
| 1 |
Arch Capital
ACGL
|
$64.1M |
| 2 |
UnitedHealth
UNH
|
$28.9M |
| 3 |
Sunrun
RUN
|
$23.8M |
| 4 |
Salesforce
CRM
|
$17.1M |
| 5 |
Nextracker
NXT
|
$11.6M |
Sector Composition
| 1 | Technology | 35.45% |
| 2 | Financials | 13.4% |
| 3 | Healthcare | 12.81% |
| 4 | Communication Services | 10.08% |
| 5 | Consumer Discretionary | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Nuvalent
NUVL
$5.83B
| $916K | 0.01% |
11,500
| – | – |
|
502
Revvity
RVTY
$10.1B
| $900K | 0.01% |
+9,200
| New | +$900K |
|
503
Ulta Beauty
ULTA
$23.1B
| $892K | 0.01% |
+1,947
| New | +$892K |
|
504
Rogers Communications
RCI
$19.4B
| $880K | 0.01% |
+16,171
| New | +$880K |
|
505
ON Semiconductor
ON
$20.1B
| $875K | 0.01% |
16,660
+4,200
| +34% | +$221K |
|
506
United Natural Foods
UNFI
$1.75B
| $874K | 0.01% |
38,368
+17,224
| +81% | +$392K |
|
507
Owens Corning
OC
$13B
| $870K | 0.01% |
+6,337
| New | +$870K |
|
508
State Street
STT
$32B
| $849K | 0.01% |
+8,350
| New | +$849K |
|
509
Vertiv
VRT
$47.4B
| $848K | 0.01% |
+6,669
| New | +$848K |
|
510
Immunovant
IMVT
$2.99B
| $845K | 0.01% |
52,500
| – | – |
|
511
Hewlett Packard
HPE
$31B
| $845K | 0.01% |
45,980
+36,480
| +384% | +$670K |
|
512
Soleno Therapeutics
SLNO
$3.71B
| $833K | 0.01% |
+10,000
| New | +$833K |
|
513
Exelon
EXC
$43.9B
| $829K | 0.01% |
19,354
-180,017
| -90% | -$7.71M |
|
514
Dr. Reddy's Laboratories
RDY
$11.9B
| $814K | 0.01% |
+53,465
| New | +$814K |
|
515
Intellia Therapeutics
NTLA
$1.29B
| $814K | 0.01% |
85,100
+63,000
| +285% | +$602K |
|
516
Quest Diagnostics
DGX
$20.5B
| $811K | 0.01% |
+4,577
| New | +$811K |
|
517
Packaging Corp of America
PKG
$19.8B
| $796K | 0.01% |
+4,200
| New | +$796K |
|
518
Progyny
PGNY
$1.94B
| $778K | 0.01% |
35,528
| – | – |
|
519
Crown Holdings
CCK
$11B
| $776K | 0.01% |
+7,500
| New | +$776K |
|
520
Arrowhead Research
ARWR
$4.02B
| $756K | 0.01% |
47,000
| – | – |
|
521
Protagonist Therapeutics
PTGX
$3.77B
| $752K | 0.01% |
13,500
| – | – |
|
522
Archer Daniels Midland
ADM
$30.2B
| $747K | 0.01% |
+14,369
| New | +$747K |
|
523
Southern Copper
SCCO
$83.6B
| $734K | 0.01% |
7,234
-438
| -6% | -$44.5K |
|
524
Apellis Pharmaceuticals
APLS
$3.55B
| $732K | 0.01% |
42,000
| – | – |
|
525
Pultegroup
PHM
$27.7B
| $728K | 0.01% |
+6,937
| New | +$728K |
|